薏苡附子败酱散治疗溃疡性结肠炎疗效的Meta分析

李红琳; 薛怡; 陈江

doi:10.3969/j.issn.1671-038X.2021.02.10

薏苡附子败酱散治疗溃疡性结肠炎疗效的Meta分析

- 1 上海中医药大学(上海, 201203);
- 2 上海中医药大学苏州市中医医院
基金项目:
江苏省中医药管理局项目(No:YB201954)

苏州市科技局民生科技基金(医疗卫生应用基础研究项目)(No:sys2018093)

详细信息

通讯作者: 陈江,E-mail:cj09203@163.com

中图分类号: R574.62

收稿日期: 2020-08-08

A Meta-analysis of therapeutic effect of Yiyi Fuzi Baijiang powder on ulcerative colitis

- 1 Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China;
- 2 Suzhou Hospital of Traditional Chinese Medicine, Shanghai University of Chinese Medicine, Suzhou, 215009, China

More Information

Corresponding author: CHEN Jiang, E-mail: cj09203@163.com

Received Date: 08 August 2020

摘要

摘要: 目的:评价薏苡附子败酱散治疗溃疡性结肠炎(UC)的有效性。方法:通过计算机检索中国知网、维普、万方、PubMed以及Embas等数据库,并辅以手工检索的方法,对关于薏苡附子败酱散治疗UC的随机对照实验研究进行筛选,文献检索时限为自数据库建立至今,对纳入的文献资料采用RevMan5.3进行Meta分析。结果:最终共纳入9篇文献,Meta分析结果显示:附子败酱散治疗UC与西药组比较,总有效率OR=3.25,95%CI:2.15~4.89,Z=5.63(P<0.01);肠黏膜组织学疗效OR=4.98,95%CI:2.55~9.73,Z=4.71(P<0.01);降低炎性因子水平(1)TNF-α:MD=-6.08,95%CI:-7.83~-4.32,Z=6.79(P<0.01),(2)IL-6:MD=-8.18,95%CI:-10.11~-6.25,Z=8.32(P<0.01);不良反应OR=0.58,95%CI:0.10~3.44,Z=0.60(P>0.01)。结论:薏苡附子败酱散单用或联合其他药物治疗UC,临床总有效率、肠黏膜组织疗效以及降低炎性因子TNF-α、IL-6的效果高于对照组,2组不良反应比较,差异无统计学意义。但纳入的文献数量有限,上述研究故仍需要更多高质量的文献数据加以验证。
- 薏苡附子败酱散 /
- 溃疡性结肠炎 /
- Meta分析
Abstract: Objective: To evaluate the efficacy of Yiyi Fuzi Baijiang powder in the treatment of ulcerative colitis.Methods: A computer-based search of CNKI,VIP,Wanfang,PubMed and Embase databases was conducted to screen the randomized controlled trials on the treatment of ulcerative colitis with Yiyi Fuzi Baijiang powder.The included literatures were analyzed by revman5.3 software.Results: A total of 9 literatures were included in the meta-analysis.The total effective rate was OR=3.25,95%CI: 2.15-4.89,Z=5.63(P<0.01);the histological efficacy of intestinal mucosa was OR=4.98,95%CI: 2.55-9.73,Z=4.71(P<0.01);the level of inflammatory factors was decreased:(1)TNF-α:MD=-6.08,95%CI:-7.83--4.32,Z=6.79(P<0.01),(2)IL-6:MD=-8.18,95%CI:-10.11--6.25,Z=8.32(P<0.01).The adverse reactions were OR=0.58,95%CI: 0.10-3.44,Z=0.60(P>0.01).Conclusion: Yiyi Fuzi Baijiang powder alone or combined with other drugs in the treatment of ulcerative colitis,the clinical total effective rate,the curative effect of intestinal mucosa tissue and the effect of reducing inflammatory factors TNF-α and IL-6 are higher than those of the control group.The adverse reactions have no statistical difference.However,the number of included literatures is limited,more high-quality literature data are needed to verify our results.
- Yiyi Fuzi Baijiang powder /
- ulcerative colitis /
- Meta-analysis

HTML全文

参考文献(15)

[1]	郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:129-134.
[2]	张双喜,宋晓锋,张相安,等.薏苡附子败酱散联合美沙拉嗪对溃疡性结肠炎患者的临床疗效[J].中成药,2019,41(11):2642-2646.
[3]	邱庐山,张双喜,王维琼,等.薏苡附子败酱散保留灌肠治疗溃疡性结肠炎临床效果观察[J].内蒙古中医药,2018,37(12):27-28.
[4]	王春成.加味附子薏苡败酱散合并锡类散灌肠治疗慢性溃疡性结肠炎86例临床观察[J].光明中医,2009,24(7):1354-1355.
[5]	刘梅英.薏苡附子败酱散加减配合中药灌肠治疗溃疡性结肠炎30例[J].河南中医,2009,29(7):639-640.
[6]	袁援.薏苡附子败酱散保留灌肠结合柳氮磺胺吡啶治疗溃疡性结肠炎临床研究[J].国际中医中药杂志,2017,39(3):221-224.
[7]	周志军,王威.薏苡附子败酱散对脾肾阳虚型溃疡性结肠炎患者的临床疗效观察:附80例报告[J].中国中西医结合急救杂志,2017,24(4):419-422.
[8]	叶道冰,宋红旗,李宾,等.薏苡附子败酱散加味联合康复新液治疗溃疡性结肠炎36例疗效观察[J].中国民族民间医药,2013,22(15):84,90.
[9]	吕立群,李艳,张磊.中药保留灌肠联合灸法治疗溃疡性结肠炎的随机对照研究[J].世界中西医结合杂志,2017,12(7):970-973.
[10]	钱惠泉.薏苡附子败酱散加味治疗溃疡性结肠炎36例[J].河北中医,2005,27(3):196-197.
[11]	李景南.溃疡性结肠炎癌变机制的研究进展——从炎症到肿瘤[J].中华消化杂志,2011,31(3):183-186.
[12]	梁笑楠,尹凤荣,张晓岚.炎症性肠病诊断与治疗的共识意见(2018年,北京)溃疡性结肠炎部分解读[J].临床荟萃,2018,33(11):987-990.
[13]	牛斌斌,叶树凤,陈宝余,等.美沙拉嗪颗粒联合康复新液治疗溃疡性结肠炎的Meta分析[J].中成药,2014,36(11):2275-2279.
[14]	刘金响,袁敏惠,杜晓泉,等.康复新液保留灌肠治疗放射性直肠炎的Meta分析[J].中国中西医结合消化杂志,2019,27(10):753-757.
[15]	韩亮,刘昌辉.败酱草提取物对三硝基苯磺酸诱导的大鼠结肠炎的保护作用[J].广东药学院学报,2013,29(1):73-75.